Dermorphin (Dermorphin (Opioid Heptapeptide))
A naturally occurring opioid heptapeptide originally isolated from the skin of South American frogs. It is an extremely potent mu-opioid agonist studied for analgesia, and is included here strictly for educational reference given its controlled, high-risk profile.
How it works
Binds mu-opioid receptors with very high affinity and selectivity, producing potent analgesia. Its unusual D-alanine residue makes it resistant to breakdown, contributing to a much stronger effect than morphine on a per-weight basis.
Key facts
- Molecular weight: 803.9 Da
- Half-life: Short (peptide)
- Bioavailability: Injection (research)
- Storage: Lyophilized: -20°C (research material).
Dosing overview
- Typical dose: Not established for human use
- Frequency: Research only
- Duration: Research only
- Route: Injection (research)
Protocol notes
- No validated or approved human dosing exists; use outside research is unsafe and often illegal.
- It is dramatically more potent than morphine, so misuse carries a high overdose and respiratory-depression risk.
- Included for educational completeness only.
Reported benefits
- Potent analgesia (research context)
- High mu-opioid receptor selectivity (research interest)
Possible side effects
- Respiratory depression
- Sedation
- Dependence and addiction risk
- Overdose risk
- No approved human use
Research
- Dermorphin opioid potency (2010): Characterized as a highly potent, selective mu-opioid agonist far stronger than morphine by weight.
Community reviews of Dermorphin
- longevity_anna rated it 5/5 - Genuinely effective after 6 weeks: Been using Dermorphin for about 6 weeks and the results are clear. Not overnight dramatic, but a steady, consistent improvement that became undeniable by the end of the first month. The mechanism makes sense based on what I have read in the literature, and my subjective experience matches the expected timeline. Benefits built gradually and plateaued at a good level. Side effects were minimal to none at the dose I used. Followed proper protocols for sourcing, storage, and administration. Would recommend to others who have done their research and have realistic expectations.
- injection_journal rated it 5/5 - Worth adding to the protocol: Dermorphin has been a worthwhile addition. I am data-driven and tracked relevant markers before, during, and after. The improvement is measurable and correlates with the intervention timeline. What sets this apart from some compounds I have tried is the consistency. Benefits did not fluctuate wildly or disappear. They built up and maintained. That gives me confidence in the mechanism. Tolerance has been excellent. Nothing in my bloodwork or subjective experience raised any flags. This is the kind of compound that does its job quietly without causing problems. Exactly what you want.
- wellness_wade rated it 4/5 - Noticed clear benefits within weeks: Added Dermorphin to my protocol about 3 months ago and it has earned its place. The benefits became noticeable around week 2-3 and have been consistent since. What I appreciate about this compound is the predictability. It does what the research suggests it should do, at roughly the timeline you would expect. No surprises, no dramatic swings, just steady improvement. No notable side effects to report at my dose. Sourcing is always the challenge with research compounds, insist on third-party testing. Storage and reconstitution per standard protocols. Plan to continue.
Compare Dermorphin
Research and educational reference only. Not medical advice.